2
|
Miao X, Wu J, Chen H, Lu G. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation. Nutrients 2022; 14:nu14091690. [PMID: 35565658 PMCID: PMC9102325 DOI: 10.3390/nu14091690] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 04/13/2022] [Accepted: 04/15/2022] [Indexed: 02/01/2023] Open
Abstract
The cytosolic PNGase (peptide:N-glycanase), also known as peptide-N4-(N-acetyl-β-glucosaminyl)-asparagine amidase, is a well-conserved deglycosylation enzyme (EC 3.5.1.52) which catalyzes the non-lysosomal hydrolysis of an N(4)-(acetyl-β-d-glucosaminyl) asparagine residue (Asn, N) into a N-acetyl-β-d-glucosaminyl-amine and a peptide containing an aspartate residue (Asp, D). This enzyme (NGLY1) plays an essential role in the clearance of misfolded or unassembled glycoproteins through a process named ER-associated degradation (ERAD). Accumulating evidence also points out that NGLY1 deficiency can cause an autosomal recessive (AR) human genetic disorder associated with abnormal development and congenital disorder of deglycosylation. In addition, the loss of NGLY1 can affect multiple cellular pathways, including but not limited to NFE2L1 pathway, Creb1/Atf1-AQP pathway, BMP pathway, AMPK pathway, and SLC12A2 ion transporter, which might be the underlying reasons for a constellation of clinical phenotypes of NGLY1 deficiency. The current comprehensive review uncovers the NGLY1’ssdetailed structure and its important roles for participation in ERAD, involvement in CDDG and potential treatment for NGLY1 deficiency.
Collapse
Affiliation(s)
- Xiangguang Miao
- Queen Mary School, Nanchang University, No. 1299 Xuefu Avenue, Honggutan New District, Nanchang 330036, China;
| | - Jin Wu
- Laboratory of Translational Medicine Research, Department of Pathology, Deyang People’s Hospital, No. 173 First Section of Taishanbei Road, Jingyang District, Deyang 618000, China;
- Deyang Key Laboratory of Tumor Molecular Research, No. 173 First Section of Taishanbei Road, Jingyang District, Deyang 618000, China
- Department of Molecular & Cellular Biology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA
| | - Hongping Chen
- Department of Histology and Embryology, Medical College of Nanchang University, Nanchang 330006, China
- Correspondence: (H.C.); (G.L.); Tel.: +86-188-0147-4087 (G.L.)
| | - Guanting Lu
- Laboratory of Translational Medicine Research, Department of Pathology, Deyang People’s Hospital, No. 173 First Section of Taishanbei Road, Jingyang District, Deyang 618000, China;
- Deyang Key Laboratory of Tumor Molecular Research, No. 173 First Section of Taishanbei Road, Jingyang District, Deyang 618000, China
- Correspondence: (H.C.); (G.L.); Tel.: +86-188-0147-4087 (G.L.)
| |
Collapse
|
3
|
Maghodia AB, Geisler C, Jarvis DL. A new nodavirus-negative Trichoplusia ni cell line for baculovirus-mediated protein production. Biotechnol Bioeng 2020; 117:3248-3264. [PMID: 32662870 DOI: 10.1002/bit.27494] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 05/21/2020] [Accepted: 07/12/2020] [Indexed: 12/22/2022]
Abstract
Cell lines derived from Trichoplusia ni (Tn) are widely used as hosts in the baculovirus-insect cell system (BICS). One advantage of Tn cell lines is they can produce recombinant proteins at higher levels than cell lines derived from other insects. However, Tn cell lines are persistently infected with an alphanodavirus, Tn5 cell-line virus (TnCLV), which reduces their utility as a host for the BICS. Several groups have isolated TnCLV-negative Tn cell lines, but none were thoroughly characterized and shown to be free of other adventitious viruses. Thus, we isolated and extensively characterized a new TnCLV-negative line, Tn-nodavirus-negative (Tn-NVN). Tn-NVN cells have no detectable TnCLV, no other previously identified viral contaminants of lepidopteran insect cell lines, and no sequences associated with any replicating virus or other viral adventitious agents. Tn-NVN cells tested negative for >60 species of Mycoplasma, Acholeplasma, Spiroplasma, and Ureaplasma. Finally, Tn-NVN cells grow well as a single-cell suspension culture in serum-free medium, produce recombinant proteins at levels similar to High Five™ cells, and do not produce recombinant glycoproteins with immunogenic core α1,3-fucosylation. Thus, Tn-NVN is a new, well-characterized TnCLV-negative cell line with several other features enhancing its utility as a host for the BICS.
Collapse
Affiliation(s)
| | | | - Donald L Jarvis
- GlycoBac, LLC, Laramie, Wyoming.,Department of Molecular Biology, University of Wyoming, Laramie, Wyoming
| |
Collapse
|
6
|
Lee KJ, Gil JY, Kim SY, Kwon O, Ko K, Kim DI, Kim DK, Kim HH, Oh DB. Molecular characterization of acidic peptide:N-glycanase from the dimorphic yeast Yarrowia lipolytica. J Biochem 2014; 157:35-43. [PMID: 25147194 DOI: 10.1093/jb/mvu051] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Peptide:N-glycanase (PNGase) A is used preferentially to cleave the glycans from plant and insect glycopeptides. Although many putative PNGase A homologous genes have been found in the plant and fungus kingdoms through sequence similarity analyses, only several PNGases from plants and one from a filamentous fungus have been characterized. In this study, we identified and characterized a PNGase A-like enzyme, PNGase Yl, in the dimorphic yeast Yarrowia lipolytica. The corresponding gene was cloned and recombinantly expressed in Pichia pastoris. The purified enzyme cleaved glycans from glycopeptides with the maximum activity at pH 5. No metal ions were required for full activity, and rather it was repressed by three metal ions (Fe(3+), Cu(2+) and Zn(2+)). Using glycopeptide substrates, PNGase Yl was shown to release various types of N-glycans including high-mannose and complex-type glycans as well as glycans containing core-linked α(1,3)-fucose that are frequently found in plants and insects. Moreover, in comparison with PNGase A, PNGase Yl was able to cleave with higher efficiency the glycans from some denatured glycoproteins. Taken together, our results suggest that PNGase Yl, the first biochemically characterized yeast PNGase A homologue, can be developed through protein engineering as a useful deglycosylation tool for N-glycosylation study.
Collapse
Affiliation(s)
- Kyung Jin Lee
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Jin Young Gil
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Sang-Yoon Kim
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Ohsuk Kwon
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Kisung Ko
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Dong-Il Kim
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Dae Kyong Kim
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Ha Hyung Kim
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| | - Doo-Byoung Oh
- Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea Biochemicals and Synthetic Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-Gu, Daejeon 305-806, Korea; Department of Medicine, Chung-Ang University, Seoul 156-756, Korea; Biosystems and Bioengineering Program, University of Science and Technology (UST), Daejeon 305-350, Korea; Department of Biological Engineering, Inha University, Incheon 402-751, Korea; and College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea
| |
Collapse
|
7
|
Zhang N, Cannon RD, Holland BR, Patchett ML, Schmid J. Impact of genetic background on allele selection in a highly mutable Candida albicans gene, PNG2. PLoS One 2010; 5:e9614. [PMID: 20231904 PMCID: PMC2834760 DOI: 10.1371/journal.pone.0009614] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2009] [Accepted: 02/16/2010] [Indexed: 11/19/2022] Open
Abstract
In many microbes rapid mutation of highly mutable contingency genes continually replenishes a pool of variant alleles from which the most suitable are selected, assisting in rapid adaptation and evasion of the immune response. In some contingency genes mutability is achieved through DNA repeats within the coding region. The fungal human pathogen Candida albicans has 2600 repeat-containing ORFs. For those investigated (ALS genes, HYR1, HYR2, CEK1, RLM1) many protein variants with differing amino acid repeat regions exist, as expected for contingency genes. However, specific alleles dominate in different clades, which is unexpected if allele variation is used for short-term adaptation. Generation of new alleles of repeat-containing C. albicans ORFs has never been observed directly. Here we present evidence for restrictions on the emergence of new alleles in a highly mutable C. albicans repeat-containing ORF, PNG2, encoding a putative secreted or cell surface glycoamidase. In laboratory cultures new PNG2 alleles arose at a rate of 2.8×10−5 (confidence interval 3.3×10−6−9. 9×10−5) per cell per division, comparable to rates measured for contingency genes. Among 80 clinical isolates 17 alleles of different length and 23 allele combinations were distinguishable; sequence differences between repeat regions of identical size suggest the existence of 36 protein variants. Specific allele combinations predominated in different genetic backgrounds, as defined by DNA fingerprinting and multilocus sequence typing. Given the PNG2 mutation rate, this is unexpected, unless in different genetic backgrounds selection favors different alleles. Specific alleles or allele combinations were not preferentially associated with C. albicans isolates from particular body sites or geographical regions. Our results suggest that the mutability of PNG2 is not used for short-term adaptation or evasion of the immune system. Nevertheless the large number of alleles observed indicates that mutability of PNG2 may assist C. albicans strains from different genetic backgrounds optimize their interaction with the host in the long term.
Collapse
Affiliation(s)
- Ningxin Zhang
- Institute of Molecular BioSciences, Massey University, Palmerston North, New Zealand
| | - Richard D. Cannon
- Department of Oral Sciences, University of Otago, Dunedin, New Zealand
| | - Barbara R. Holland
- Allan Wilson Centre for Molecular Ecology and Evolution, Massey University, Palmerston North, New Zealand
| | - Mark L. Patchett
- Institute of Molecular BioSciences, Massey University, Palmerston North, New Zealand
| | - Jan Schmid
- Institute of Molecular BioSciences, Massey University, Palmerston North, New Zealand
- * E-mail:
| |
Collapse
|